Market Research Logo

Octapharma AG

Octapharma AG - Strategy and SWOT Report,

- is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Features:

  • Detailed information on Octapharma AG required for business and competitor intelligence needs
  • A study of the major internal and external factors affecting Octapharma AG in the form of a SWOT analysis
  • An in-depth view of the business model of Octapharma AG including a breakdown and examination of key business segments
  • Intelligence on Octapharma AG’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
  • News about Octapharma AG, such as business expansion, restructuring, and contract wins
  • Large number of easy-to-grasp charts and graphs that present important data and key trends
Highlights:

Octapharma (or 'the group') is engaged in the research and development of human proteins for various therapeutic areas. It is a private group that provides products for the treatment of coagulation disorders and immune diseases, and also offers intensive care and emergency medicines. The group operates in Europe, North and South Americas, Asia Pacific and the Middle East. It is headquartered in Lachen, Switzerland, and employed 5,514 people as on December 31, 2013.Reasons to Purchase:

  • Gain understanding of Octapharma AG and the factors that influence its strategies
  • Track strategic initiatives of the company and latest corporate news and actions
  • Assess Octapharma AG as a prospective partner, vendor or supplier
  • Support sales activities by understanding your customers' businesses better
  • Stay up to date on Octapharma AG’s business structure, strategy and prospects

  • Company Snapshot
    Octapharma AG: Company Overview
    Octapharma AG: Overview and Key Facts
    Octapharma AG: Overview
    Octapharma AG: Key Facts
    Octapharma AG: Key Employees
    Octapharma AG: Major Products and Services
    Octapharma AG: Company History
    Octapharma AG: Management Statement
    Octapharma AG: Locations and Subsidiaries
    Octapharma AG: Key Competitors
    Octapharma AG: Company Analysis
    Octapharma AG: Business Description
    Octapharma AG: SWOT Analysis
    Octapharma AG: SWOT Overview
    Octapharma AG: Strengths
    Octapharma AG: Weaknesses
    Octapharma AG: Opportunities
    Octapharma AG: Threats
    Octapharma AG: Corporate Financial Deals Activity
    Octapharma AG: Financial Deals Overview
    Octapharma AG: Targets and Partners
    Octapharma AG: Top Deals 2011 - 2015YTD*
    Octapharma AG: Corporate Venturing
    Octapharma AG: Partnership
    Octapharma AG: Recent Developments
    Octapharma AG: News and Events Summary
    Octapharma AG: Business Expansion
    Octapharma AG: Contracts
    Octapharma AG: Financial Performance
    Octapharma AG: Regulatory and Legal Events
    Octapharma AG: Research & Development
    Appendix
    Contact Us
    Methodology
    Definitions
    About Market Line
    List of Tables
    Table 1: Octapharma AG: Key Facts
    Table 2: Octapharma AG: Key Employees
    Table 4: Octapharma AG: Key Competitors
    Table 5: Octapharma AG: Deal Activity by Deal Type - Volume (TTM*)
    Table 6: Octapharma AG: Deal Activity by Deal Type - Volume (2011 - YTD*2015)
    Table 7: Octapharma AG: Targets and Partners
    Table 8: Octapharma AG: Top Deals 2011 - 2015YTD*
    Table 9: Octapharma AG: Corporate Venturing Volume and Value Trend (2011 - YTD*2015)
    Table 10: Octapharma AG: Corporate Venturing by Geography (2011 - YTD*2015)
    Table 11: Octapharma AG: Partnership Volume and Value Trend (2011 - YTD*2015)
    Table 12: Octapharma AG: Partnership Trend by Deal Type (2011 - YTD*2015)
    Table 13: Octapharma AG: News and Events Summary
    Table 14: Octapharma AG: Business Expansion
    Table 15: Octapharma AG: Contracts
    Table 16: Octapharma AG: Financial Performance
    Table 17: Octapharma AG: Regulatory and Legal Events
    Table 18: Octapharma AG: Research & Development
    List of Figures
    Figure 1: Octapharma AG: Deal Activity by Deal Type - Volume (TTM*)
    Figure 2: Octapharma AG: Deal Activity by Deal Type - Volume (2011 - YTD*2015)
    Figure 3: Octapharma AG: Corporate Venturing Volume and Value Trend (2011 - YTD*2015)
    Figure 4: Octapharma AG: Corporate Venturing by Geography (2011 - YTD*2015)
    Figure 5: Octapharma AG: Partnership Volume and Value Trend (2011 - YTD*2015)
    Figure 6: Octapharma AG: Partnership Trend by Deal Type (2011 - YTD*2015)

    Download our eBook: How to Succeed Using Market Research

    Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

    Download eBook

    Share this report